Related Experiment Video

Updated: May 22, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

Retinoblastoma protein determines aggressiveness in triple-negative breast cancer

Jimmy Jacob1, Adam E Frampton, Leandro Castellano

  • 1Division of Cancer, Department of Surgery and Cancer, Imperial College, Hammersmith Hospital, Du Cane Road, London, UK. j.jacob@imperial.ac.uk

Expert Review of Anticancer Therapy
|May 19, 2012
PubMed

Insights

Retinoblastoma protein (RB) inactivation triggers epithelial-to-mesenchymal transition (EMT) by downregulating miR-200 and upregulating ZEB, promoting aggressive cancer phenotypes. This link offers potential therapeutic targets for triple-negative breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Retinoblastoma protein (RB) is a critical tumor suppressor involved in cell cycle control and other pathways deregulated in cancer.
  • Epithelial-to-mesenchymal transition (EMT) is a process linked to tumor progression and metastasis, characterized by loss of cell adhesion and polarity.
  • Previous studies indicated RB depletion initiates EMT by downregulating E-cadherin.

Discussion:

  • This study investigates the molecular mechanisms by which RB inactivation promotes EMT.
  • RB inactivation leads to the downregulation of the miR-200 family, a key regulator of EMT.
  • This downregulation results in the upregulation of ZEB, a transcription factor that represses E-cadherin expression, thereby inducing EMT.

Key Insights:

  • RB inactivation contributes to both loss of cell cycle control and EMT.
  • The RB-miR-200-ZEB axis is identified as a crucial pathway driving EMT.
  • RB inactivation is implicated as a key event in the aggressive phenotype of triple-negative breast cancer.

Outlook:

  • Understanding the RB-EMT connection may reveal novel therapeutic strategies for triple-negative breast cancer.
  • Targeting this pathway could potentially reverse mesenchymal characteristics and reduce metastasis.
  • Further research into RB's role in EMT could uncover new biomarkers for cancer prognosis and treatment.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...